La Madonnina Clinic
La Madonnina Clinic
Italie, Milan
| Italie | Turquie | Espagne | |
| Thérapie par cellules souches | de $10,000 | de $7,300 | de $8,500 |
| Thérapie hormonale | de $2,500 | de $408 | de $3,000 |
| Résection de la vésicule biliaire | de $7,000 | de $2,900 | de $3,000 |
| Аphérèse sélective | de $3,100 | de $1,550 | - |
Bookimed ne rajoute pas de frais pour les traitements de La maladie de Crohn. Les tarifs proviennent des listes de prix officielles des cliniques. Vous payez directement à la clinique pour votre traitement à votre arrivée dans le pays.
Bookimed s'engage pour votre sécurité. Nous ne travaillons qu'avec des établissements médicaux qui respectent des normes internationales élevées dans le traitement de La maladie de Crohn et qui possèdent les licences nécessaires pour accueillir des patients internationaux dans le monde entier.
Bookimed offre une assistance experte gratuite. Un coordinateur médical personnel vous accompagne avant, pendant et après votre traitement, en résolvant tous les problèmes. Vous n'êtes jamais seul dans votre parcours de traitement de La maladie de Crohn.
Advanced Crohn's disease treatments in Italy include IL-23 inhibitors like Risankizumab and oral JAK inhibitors such as Upadacitinib. Specialized centers offer stem cell therapy for refractory cases. Leading facilities in Milan and Rome provide biologic therapies, clinical trials, and gut-selective integrin inhibitors for targeted inflammation control.
Bookimed Expert Insight: While many search for the newest drugs, the real advantage in Italy is the integration of research hubs. Mater Olbia Hospital in Rome combines expertise from the Qatar Foundation and Fondazione Policlinico Gemelli. This partnership allows patients to access clinical trials for advanced combination treatments (ACT). These protocols use multiple biologics simultaneously for cases that do not respond to standard care.
Patient Consensus: Patients note that seeking private consultations can significantly shorten wait times for high-demand biologics like Ustekinumab. Many suggest preparing detailed flare history and medical records to fast-track approvals within specialized regional networks.
Italy hosts leading centers for Crohns disease specializing in biological therapies and advanced diagnostics. Humanitas Research Hospital and Agostino Gemelli University Policlinic serve as primary referral hubs. These facilities utilize multidisciplinary teams including specialized surgeons and gastroenterologists to manage complex inflammatory bowel conditions.
Bookimed Expert Insight: Patients seeking premium care often choose La Madonnina Clinic in Milan. It is part of the San Donato Network and treats high-profile individuals. While it is a private facility, its link to major research networks ensures access to top experts. This presents a faster alternative to public university hospitals where wait times are often significant.
Patient Consensus: Patients often recommend choosing university-affiliated hospitals over general facilities for better specialty care. Many note that northern Italian hospitals typically offer more updated medical protocols than southern regions.
Italy supports Crohn's disease care through the Servizio Sanitario Nazionale (SSN). It classifies the condition as a chronic illness. This status grants patients a ticket exemption for diagnostic tests and specialist visits. The system fully subsidizes biological therapies and surgical procedures in public hospitals.
Bookimed Expert Insight: Patients can navigate regional wait times by using Italy's cross-regional referral system. If a local facility is overbooked, the SSN may authorize and fund treatment in other regions. This is especially useful for complex surgeries at high-volume centers like Mater Olbia Hospital. Utilizing this legislative right ensures timely access to specialized gastroenterology teams without incurring private surgical fees.
Patient Consensus: Patients note that registering with a regional IBD hub provides a dedicated coordinator. This significantly simplifies scheduling appointments and obtaining prescriptions compared to managing standard public referrals alone.